Gregory Garland - Amgen Independent Director
AMGN Stock | MXN 4,450 0.00 0.00% |
Director
Mr. Gregory C. Garland is an Independent Director of the Company. Mr. Greg C. Garland is the Chairman and Chief Executive Officer of Phillips 66, an energy manufacturing and logistics company with midstream, chemical, refining and marketing and specialties businesses created through the repositioning of ConocoPhillips, having held this position since April 2012. Mr. Garland chairs the Executive Committee of Phillips 66. Prior to Phillips 66, Mr. Garland served as Senior Vice President, Exploration and Production, Americas of ConocoPhillips from 2010 to April 2012. He was President and Chief Executive Officer of Chevron Phillips Chemical Company from 2008 to 2010 and Senior Vice President, Planning and Specialty Chemicals from 2000 to 2008. Mr. Garland served in various positions at Phillips Petroleum Company from 1980 to 2000. Mr. Garland is a member of the Engineering Advisory Board for Texas AM University. Mr. Garland received an undergraduate degree from Texas AM University. The Board concluded that Mr. Garland should serve on our Board because of Mr. Garlands experience as a chief executive officer and his over 30 years of international experience in a highly regulated industry. since 2013.
Age | 60 |
Tenure | 11 years |
Phone | 805 447 1000 |
Web | https://www.amgen.com |
Amgen Management Efficiency
The company has return on total asset (ROA) of 0.0997 % which means that it generated a profit of $0.0997 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 1.2647 %, meaning that it generated $1.2647 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | DIRECTOR Age | ||
Stephen Forrest | Applied Materials | 66 | |
David Munoz | Grupo Carso SAB | 89 | |
Thomas Baltimore | Prudential Financial | 54 | |
William McDonald | Martin Marietta Materials | 72 | |
James Cullen | Prudential Financial | 72 | |
Aart Geus | Applied Materials | 63 | |
Dorothy Ables | Martin Marietta Materials | 60 | |
Richard Vinroot | Martin Marietta Materials | 74 | |
Dennis Powell | Applied Materials | 69 | |
Michael Quillen | Martin Marietta Materials | 69 | |
Peter Lighte | Prudential Financial | 69 | |
Michael Stein | McEwen Mining | 65 | |
Adrianna Ma | Applied Materials | 43 | |
Antonio Arino | Grupo Carso SAB | 84 | |
Claudio Gonzalez | Grupo Carso SAB | 84 | |
David Maffucci | Martin Marietta Materials | 65 | |
Laree Perez | Martin Marietta Materials | 64 | |
Arturo Ayub | Grupo Carso SAB | 53 | |
Michael Todman | Prudential Financial | 60 | |
Michele Ashby | McEwen Mining | 59 | |
Elisabeth Eisleben | Martin Marietta Materials | N/A |
Management Performance
Return On Equity | 1.26 | |||
Return On Asset | 0.0997 |
Amgen Inc Leadership Team
Elected by the shareholders, the Amgen's board of directors comprises two types of representatives: Amgen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Amgen. The board's role is to monitor Amgen's management team and ensure that shareholders' interests are well served. Amgen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Amgen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Linda Louie, VP Officer | ||
Frank Herringer, Independent Director | ||
Nancy Grygiel, Sr Officer | ||
Francois Carbonnel, Independent Director | ||
Rebecca Henderson, Independent Director | ||
Annette Such, Chief Accounting Officer | ||
Sanders Williams, Independent Director | ||
Vance Coffman, Lead Independent Director | ||
David Reese, Executive Vice President - Research and Development | ||
Tyler Jacks, Independent Director | ||
Brian McNamee, Executive Vice President - Full Potential Initiatives | ||
Gregory Garland, Independent Director | ||
Charles Holley, Director | ||
Esteban Santos, Executive Vice President Operations | ||
Jonathan Graham, Senior Vice President General Counsel, Secretary | ||
Sean Harper, Executive Vice President - Research and Development | ||
Mike Zahigian, VP Officer | ||
Ellen Kullman, Director | ||
Frank Biondi, Independent Director | ||
Arvind Sood, IR Contact Officer | ||
David Meline, CFO and Executive VP | ||
Ronald Sugar, Independent Director | ||
Stuart Tross, Senior Vice President - Human Resources | ||
Robert Bradway, Chairman, CEO and President Chairman of Executive Committee and Member of Equity Award Committee | ||
Murdo Gordon, Executive Vice President of Global Commercial Operations | ||
Peter Griffith, Ex CFO | ||
Wanda Austin, Independent Director | ||
Robert Eckert, Independent Director | ||
Madhavan Balachandran, Executive VP of Operations | ||
Lori Johnston, Senior Vice President - Human Resources | ||
Brian Druker, Independent Director | ||
Cynthia Patton, Senior Vice President Chief Compliance Officer | ||
Greg Garland, Independent Director | ||
Robert Williams, Independent Director | ||
Judith Pelham, Independent Director | ||
David Baltimore, Independent Director | ||
Fred Hassan, Director | ||
David Piacquad, Senior Vice President - Business Development | ||
Anthony Hooper, Executive VP of Global Commercial Operations | ||
David MD, Ex RD |
Amgen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Amgen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 1.26 | |||
Return On Asset | 0.0997 | |||
Profit Margin | 0.25 % | |||
Operating Margin | 0.38 % | |||
Current Valuation | 3.36 T | |||
Shares Outstanding | 533.98 M | |||
Shares Owned By Insiders | 0.20 % | |||
Shares Owned By Institutions | 80.38 % | |||
Price To Earning | 267.53 X | |||
Price To Book | 40.33 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Amgen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Amgen's short interest history, or implied volatility extrapolated from Amgen options trading.
Pair Trading with Amgen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amgen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amgen will appreciate offsetting losses from the drop in the long position's value.Moving together with Amgen Stock
0.71 | ROGN | Roche Holding AG | PairCorr |
The ability to find closely correlated positions to Amgen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amgen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amgen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amgen Inc to buy it.
The correlation of Amgen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amgen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amgen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amgen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |